4Y4

1-[2-[(2R)-2-oxidanyl-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one

Created:	2021-08-10
Last modified:	2021-09-22

Find Related PDB Entry
1 entries where 4Y4 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	1
Bond Count	53
Aromatic Bond Count	12

2D diagram of 4Y4

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-[2-[(2R)-2-oxidanyl-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one
Systematic Name (OpenEye OEToolkits)	1-[2-[(2~{R})-2-oxidanyl-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one
Formula	C₂₁ H₂₇ N O₃
Molecular Weight	341.444
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CCCNC[CH](O)COc1ccccc1C(=O)CCc2ccccc2
SMILES	OpenEye OEToolkits	2.0.7	CCCNCC(COc1ccccc1C(=O)CCc2ccccc2)O
Canonical SMILES	CACTVS	3.385	CCCNC[C@@H](O)COc1ccccc1C(=O)CCc2ccccc2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCCNC[C@H](COc1ccccc1C(=O)CCc2ccccc2)O
InChI	InChI	1.03	InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3/t18-/m1/s1
InChIKey	InChI	1.03	JWHAUXFOSRPERK-GOSISDBHSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB19162
Name	(R)-Propafenone
Groups	investigational
Description	Propafenone, (r)- is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).
Synonyms	(R)-propafenone (+)-(r)-propafenone (+)-propafenone 1-propanone, 1-(2-((2r)-2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl- (R)-Propafenone
CAS number	107381-31-7

Related Resource References

Resource Name	Reference
Pharos	CHEMBL1788268
PubChem	184819
ChEMBL	CHEMBL1788268

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.